Exosomal miR-425-3p in cisplatin-resistant non-small cell lung cancer (NSCLC) promotes autophagy activation by targeting the AKT1/mTOR pathway, leading to cisplatin resistance in sensitive cells [134]. Here, MTOR is linked to non-small cell lung carcinoma.